Latagliata R - Search Results

1

Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.

Tatarelli C, Piccioni AL, Maurillo L, Naso V, Battistini R, D'Andrea M, Criscuolo M, Nobile C, Villivà N, Mancini S, Neri B, Breccia M, Fenu S, Buccisano F, Voso MT, Latagliata R, Aloe Spiriti MA. Tatarelli C, et al. Among authors: latagliata r. Ann Hematol. 2014 Aug;93(8):1413-20. doi: 10.1007/s00277-014-2053-9. Epub 2014 Mar 20. Ann Hematol. 2014. PMID: 24647684

2

Thymopentin in the treatment of myelodysplastic syndromes.

Latagliata R, Petti MC, Aloe Spiriti MA, Tirindelli MC, Fazi P, De Gregoris C, Mandelli F. Latagliata R, et al. Acta Haematol. 1991;86(2):115. doi: 10.1159/000204816. Acta Haematol. 1991. PMID: 1950372 Free article. No abstract available.

3

Is aggressive chemotherapy the best choice for patients with acute nonlymphocytic leukemia after myelodysplastic syndromes?

Latagliata R, Spiriti MA, Avvisati G, De Gregoris C, Fazi P, Spadea A, Petti MC. Latagliata R, et al. Leuk Res. 1995 Mar;19(3):213-7. doi: 10.1016/0145-2126(94)00140-6. Leuk Res. 1995. PMID: 7700082

4

Polycythaemia vera and cerebral blood flow: a preliminary study with transcranial Doppler.

Fiermonte G, Aloe Spiriti MA, Latagliata R, Petti MC, Giacomini P. Fiermonte G, et al. Among authors: latagliata r. J Intern Med. 1993 Dec;234(6):599-602. doi: 10.1111/j.1365-2796.1993.tb01019.x. J Intern Med. 1993. PMID: 7903108

5

Erythropoietin treatment of idiopathic myelofibrosis.

Aloe Spiriti M, Latagliata R, Avvisati G, Battistel V, Montefusco E, Spadea A, Petti MC. Aloe Spiriti M, et al. Among authors: latagliata r. Haematologica. 1993 Nov-Dec;78(6):371-3. Haematologica. 1993. PMID: 8175031

6

Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim report.

Aloe Spiriti MA, Petti MC, Latagliata R, Avvisati G, De Gregoris C, Proia S, Fazi P, Jaalouk G, Mancini M, Spadea A, et al. Aloe Spiriti MA, et al. Among authors: latagliata r. Haematologica. 1993 Mar-Apr;78(2):123-6. Haematologica. 1993. PMID: 8349188

7

Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.

Spadea A, Petti MC, Fazi P, Vegna ML, Arcese W, Avvisati G, Aloe Spiriti MA, Latagliata R, Meloni G, Testi AM, et al. Spadea A, et al. Among authors: latagliata r. Leukemia. 1993 Apr;7(4):549-52. Leukemia. 1993. PMID: 8464233 Clinical Trial.

8

Bisantrene in relapsed and refractory acute myelogenous leukemia.

Spadea A, Petti MC, Aloespiriti MA, Avvisati G, De Gregoris C, Fazi P, Latagliata R, Amadori S, Mandelli F. Spadea A, et al. Among authors: latagliata r. Leuk Lymphoma. 1993 Feb;9(3):217-20. doi: 10.3109/10428199309147373. Leuk Lymphoma. 1993. PMID: 8471980

9

Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?

Aloe Spiriti MA, Petti MC, Latagliata R, Avvisati G, De Gregoris C, Proia S, Fazi P, Jaalouk G, Mancini M, Spadea A, et al. Aloe Spiriti MA, et al. Among authors: latagliata r. Leuk Lymphoma. 1993 Jan;9(1-2):79-83. doi: 10.3109/10428199309148507. Leuk Lymphoma. 1993. PMID: 8477205

10

Erythropoietin in myelodysplastic syndromes: durable response in a young patient.

Aloe Spiriti MA, Latagliata R, Petti MC. Aloe Spiriti MA, et al. Among authors: latagliata r. Haematologica. 1996 Jul-Aug;81(4):381-2. Haematologica. 1996. PMID: 8870388 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters